Menno Vergeer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Menno Vergeer has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Geesje Margaretha Dallinga-Thie
Department of Experimental Vascular Medicine, Academic Medical Center Amsterdam, the Netherlands
3 shared publications John J.P. Kastelein
3 shared publicationsArie van Tol
2 shared publicationsKay-Tee Khaw
2 shared publicationsManjinder S. Sandhu
2 shared publicationsNicholas J. Wareham
2 shared publications
Latest Publications
- 3 August 2010
- Published by Wolters Kluwer Health in Circulation
- Vol. 122 (5) , 470-477
Genetic Variation at the Phospholipid Transfer Protein Locus Affects Its Activity and High-Density Lipoprotein Size and Is a Novel Marker of Cardiovascular Disease Susceptibility
Background—In contrast to clear associations between variants in genes participating in low-density lipoprotein metabolism and cardiovascular disease risk, such associations for high-density lipoprotein (HDL)–related genes are not well supported by recent large studies. We aimed to determine whether genetic variants at the locus encoding phospholipid transfer protein (PLTP), a protein involved in HDL remodeling, underlie altered PLTP activity, HDL particle concentration and size, and cardiovascular disease risk. Methods and Results—We assessed associations between 6 PLTP tagging single nucleotide polymorphisms and PLTP activity in 2 studies (combined n=384) and identified 2 variants that show reproducible associations with altered plasma PLTP activity. A gene score based on these variants is associated with lower hepatic PLTP transcription (P=3.2×10−18) in a third study (n=957) and with an increased number of HDL particles of smaller size (P=3.4×10−17) in a fourth study (n=3375). In a combination of 5 car...
- 3 August 2010
- Published by Wolters Kluwer Health in Circulation
- Vol. 122 (5) , 470-477
Genetic Variation at the Phospholipid Transfer Protein Locus Affects Its Activity and High-Density Lipoprotein Size and Is a Novel Marker of Cardiovascular Disease Susceptibility
Background—In contrast to clear associations between variants in genes participating in low-density lipoprotein metabolism and cardiovascular disease risk, such associations for high-density lipoprotein (HDL)–related genes are not well supported by recent large studies. We aimed to determine whether genetic variants at the locus encoding phospholipid transfer protein (PLTP), a protein involved in HDL remodeling, underlie altered PLTP activity, HDL particle concentration and size, and cardiovascular disease risk. Methods and Results—We assessed associations between 6 PLTP tagging single nucleotide polymorphisms and PLTP activity in 2 studies (combined n=384) and identified 2 variants that show reproducible associations with altered plasma PLTP activity. A gene score based on these variants is associated with lower hepatic PLTP transcription (P=3.2×10−18) in a third study (n=957) and with an increased number of HDL particles of smaller size (P=3.4×10−17) in a fourth study (n=3375). In a combination of 5 car...
- Open Access
- 1 August 2010
- Published by Elsevier in Journal of Lipid Research
- Vol. 51 (8) , 2058-2073
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
- 1 August 2010
- Published by Elsevier in Journal of Lipid Research
- Vol. 51 (8) , 2058-2073
Open AccessThe HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
- 1 August 2010
- Published by Elsevier in Atherosclerosis
- Vol. 211 (2) , 558-564
Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT
- 1 August 2010
- Published by Elsevier in Atherosclerosis
- Vol. 211 (2) , 558-564
Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT
- 1 June 2008
- Published by Taylor & Francis in Future Lipidology
- Vol. 3 (3) , 327-335
Evaluation of phospholipid transfer protein as a therapeutic target
- 1 June 2008
- Published by Taylor & Francis in Future Lipidology
- Vol. 3 (3) , 327-335
Evaluation of phospholipid transfer protein as a therapeutic target